Xianghe Capital is a venture capital fund focusing on early and growth stage investments in TMT industry in China.
Business Model:
Revenue: $0
Employees: 0-0
Address: 21/F, Building C
City: Beijing
State: hainan province
Zip: -
Country: CN
Founded by Mr. Hesong Tang and Ms. Maggie Yang, Xiang He Capital is a venture capital fund focusing on early and growth stage investments in TMT industry in China. Before starting Xiang He, Mr. Tang was Baidu&s;s VP of Corporate Development, overseeing strategic investments and M&a;A, and Ms. Yang was Baidu&s;s Managing Director of Corporate Development. They have led a series of landscape-changing deals such as iQiyi, Qunar, PPS and 91 wireless, which all have a significant impact on China&s;s TMT industry. Xiang He&s;s team have a background from Corporate Development of Baidu, other leading internet companies, and VC funds. The team is particularly strong in strategic analysis and has deep connections in the internet industry. Xiang He&s;s investments are driven by strategic analysis and collective wisdom.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
4/2020 | DataCanvas | Series C | 17M |
3/2019 | Moka | Series B | 26.8M |
12/2016 | Yunmanman | Series D | 110M |
4/2022 | ZHIYI TECH | Series B | 100M |
10/2019 | Yunxi Technology | Series B | 49.5M |
6/2020 | Zuoyebang | Series E | 0 |
9/2022 | Mogulinker Technology | Series C | - |
6/2021 | YunQuNa | Series D | 0 |
12/2021 | Lingxing | Series C | 0 |
10/2021 | Helixon | Angel Round | 0 |
7/2020 | Sandstone | Series B | 0 |
8/2020 | Tongcheng Shenghuo | Series C | - |
3/2018 | Infervision | Series B | 47.4M |
9/2016 | Zuoyebang | Series B | 60M |
2/2020 | Ding Dong | Series B | 10M |
12/2017 | Kuaikan Manhua | Series D | 177M |
1/2020 | Shumei Technology | Series C | 73M |
1/2017 | Lalamove | Series B | 30M |
8/2017 | Zuoyebang | Series C | 0 |
6/2021 | Iplus Mobot | Series B | - |
8/2021 | BioMap | Series A | 100M |
4/2022 | ZHIYI TECH | Series B | 0 |
5/2020 | Hotspot | Series B | - |
1/2018 | Ezcarry | Series A | 18.8M |
7/2019 | Guandata | Series B | 14.5M |
4/2021 | Aqrose Technology | Series B | - |
6/2020 | Mancando | Series B | 56.6M |
4/2018 | Sensors Data | Series C | 0 |
5/2022 | Sensors Data | Series D | 0 |
5/2020 | Sensors Data | Series C | 30M |
8/2021 | Jiepei.com | Series B | 46.3M |
1/2022 | Ractigen Therapeutics | Series A | 30M |
11/2018 | Synyi | Series B | 20.2M |
3/2018 | DataCanvas | Series B | - |
5/2019 | Beidian | Series A | 126M |
8/2020 | Rokae | Series C | 14.4M |
9/2019 | Yihui Information | Series A | 16.9M |
3/2022 | Data Grand | Series C | 0 |
5/2018 | DiYiDan | Series C | 4.7M |
12/2022 | PhiGent Robotics | Series A | - |
9/2019 | Dingdong Class | Series A | - |
4/2021 | Shumei Technology | Series D | 135M |
2/2017 | iQiyi | Series G | 1.5B |
10/2017 | Lalamove | Series C | 100M |
2/2022 | DataStory | Series C | 0 |
2/2022 | Guandata | Series C | 44.3M |
11/2020 | Aqrose Technology | Series B | 20M |
2/2019 | Huolala | Series D | 300M |
6/2022 | Helixon | Series A | 0 |
6/2022 | Helixon | Series A | 0 |
5/2022 | Sensors Data | Series D | 0 |
4/2022 | ZHIYI TECH | Venture Round | 0 |
3/2022 | Data Grand | Series C | 0 |
2/2022 | Guandata | Series C | 0 |
2/2022 | DataStory | Series C | 0 |
1/2022 | Ractigen Therapeutics | Series A | 0 |
12/2021 | Lingxing | Series C | 0 |
10/2021 | Helixon | Angel Round | 0 |
8/2021 | Jiepei.com | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|